RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,572,000 | -21.3% | 743,000 | 0.0% | 0.58% | -14.4% |
| Q2 2019 | $22,342,000 | +177.1% | 743,000 | +106.4% | 0.68% | +145.1% |
| Q1 2019 | $8,062,000 | +14.2% | 359,900 | -7.2% | 0.28% | -11.5% |
| Q4 2018 | $7,062,000 | +0.6% | 388,000 | 0.0% | 0.31% | +21.3% |
| Q3 2018 | $7,019,000 | +81.8% | 388,000 | 0.0% | 0.26% | +61.2% |
| Q2 2018 | $3,861,000 | +87.4% | 388,000 | 0.0% | 0.16% | +66.7% |
| Q1 2018 | $2,060,000 | +41.1% | 388,000 | +288.0% | 0.10% | +15.7% |
| Q3 2017 | $1,460,000 | -22.1% | 100,000 | 0.0% | 0.08% | -29.1% |
| Q2 2017 | $1,874,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,031,562 | $17,268,000 | 2.42% |
| NEA Management Company, LLC | 3,493,636 | $29,696,000 | 1.23% |
| VHCP Management II, LLC | 544,612 | $4,629,000 | 1.11% |
| RA Capital Management | 1,351,808 | $11,490,000 | 0.96% |
| Rock Springs Capital Management LP | 600,000 | $5,100,000 | 0.23% |
| Rhenman & Partners Asset Management AB | 108,451 | $922,000 | 0.12% |
| Tekla Capital Management LLC | 356,237 | $3,028,000 | 0.12% |
| ELLINGTON MANAGEMENT GROUP LLC | 34,900 | $297,000 | 0.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 79,150 | $673,000 | 0.03% |
| Candriam S.C.A. | 151,000 | $1,284,000 | 0.02% |